Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer

• Daniel Abate-Daga ,

  * E-mail: daniel.abate-daga@nih.gov

  Affiliation Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Daniel E. Speiser,

  Affiliation Department of Oncology, Ludwig Center, University of Lausanne, Lausanne, Switzerland

  ⨯
• Nachimuthu Chinnasamy,

  Affiliation Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Zhili Zheng,

  Affiliation Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Hui Xu,

  Affiliation Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Steven A. Feldman,

  Affiliation Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Steven A. Rosenberg,

  Affiliation Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Richard A. Morgan

  Current address: Bluebird Bio, Cambridge, Massachusetts, United States of America

  Affiliation Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯